Calcium Homeostasis in Human Heart Failure

Advances in Organ Biology

Volumn 4, Issue C, 1998, Pages 63-79

  Schmidt, Ulrich ^a   Hajjar, Roger J ^a   Carles, Maria ^a   Gwathmey, Judith K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1642332513     PISSN: 15692590     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2590(08)60081-6     Document Type: Article

References (72)

1. Anderson P.A., Oakley A.E., Pagani E.D., and Allen P.D. Troponin T isoform expression in humans: A comparison among normal and failing adult heart and adult and fetal skeletal muscle. Circ. Res. 69 (1991) 1226-1233
2. Arai M., Matsui H., and Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ. Res. 74 (1994) 555-564
3. Barry W.H., and Bridge J.H.B. Intracellular calcium homeostasis in cardiac myocytes. Circ. Res. 8 (1993) 1806-1815
4. 2+], handling in human ventricular myocytes from patients with terminal heart failure. Am. Heart. J. 29 (1995) 684-689
5. Beuckelmann D.J., Näbauer M., and Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 85 (1992) 1046-1055
6. Bing O.H.L., Brooks W.W., Conrad C.H., Sen S., Perreault C.L., and Morgan J.P. Intracellular calcium transients in myocardium from spontaneously hypertensive rats during the transition to heart failure. Circ. Res. 68 (1991) 1390-1400
7. Bohm M., Reiger B., Schwinger R.H.G., and Erdmann E. cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in nonfailing and failing myocardium. Cardiovasc. Res. 28 (1994) 1713-1719
8. Brillantes A.M., Allen P., Takahashi T., Izumo S., and Marks A.R. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with endstage heart failure caused by ischemic vs.dilated cardiomyopathy. Circ. Res. 70 (1992) 1225-1232
9. Cannell M.B., Cheng H., and Lederer W.H. The control of calcium release in heart muscle. Science 268 (1995) 1045-1049
10. D'Agnolo, A., Luciani, G. B., Mazzucco, A., Gallucci, V., and Salvati, G. Contractile properties and Ca2+ release activity of the sarcoplasmic reticulum in dilated cardiomyopathy. Circulation 85 518-525
11. Fabiato A. Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac purkinje cell. J. Gen. Physiol. 85 (1985) 247-290
12. Feldman M.D., Copelas L., Gwathmey J.K., Phillips P., Warren S.E., Schoen F.J., Grossman W., and Morgan J.P. Deficient production of cyclic AMP: Pharmacological evidence for an important cause of contractile dysfunction in patients with endstage heart failure. Circulation 75 (1987) 331-339
13. 2+ ATPase and phospholamban mRNA and protein levels due to ischemic or dilated cardiomyopathy. J. Mol. Med. (in press).
14. 2+-exchanger in the failing human myocardium. Circulation (in press).
15. 2+-dependent proteolysis?. Circ. Res. 78 (1996) 45-65
16. Genao, A., Seth, K., Schmidt, U., Carles, M., and Gwathmey, J. K. 1996 Dilated cardiomyopathy in turkeys: An animal model for the study of human heart failure. AALAS (in press).
17. Gruver E.J., Glass M.G., Marsh J.D., and Gwathmey J.K. An animal model of dilated cardiomyopathy: Characterization of dihydropyridine receptors and contractile performance. Am. J. Physiol. 265 (1993) H1704-H1711
18. Gruver E.J., Morgan J.P., Stumble B.S., and Gwathmey J.K. Uniformity of calcium channel number and isometric contraction in human right and left ventricular myocardium. Bas. Res. Cardiol. 89 (1994) 139-148
19. Gwathmey J.K. Experimental cardiomyopathies. In: Braunwald E., and Abelmann W.H. (Eds). Atlas of Heart Diseases, Cardiomyopathies, Myocarditis, and Pericardial Disease (1995), Imago Productions (FE) 1-21 Singapore
20. Gwathmey J.K., Liao R., and Hajjar R.J. Intracellular free calcium in hypertrophy and failure. In: Lorell B.H., and Grossman W.G. (Eds). Diastolic Relaxation in the Heart (1994), Kluwer Academic Publishing, Boston 55-64
21. Gwathmey J.K., and Davidoff A.J. Pathophysiology of cardiomyopathies. Part I. Animal models and humans. Current Opinion in Cardiology 9 (1994) 369-378
22. Gwathmey J.K., Hajjar R.J., and Allen P.D. Excitation -contraction coupling in human ventricular myocardium: Relationship to the pathophysiology of heart failure. In: Gwathmey J.K., Briggs G.M., and Allen P.D. (Eds). Heart Failure Basic Science and Clinical Aspects (1993), Marcel Dekker, Inc., New York 121-144
23. Gwathmey J.K., and Davidoff A.J. Experimental aspects of cardiomyopathy. Curr. Opin. Cardiol. 8 (1993) 480-495
24. 2+ regulation with resultant implications on contractile performance. J. Mol. Cell. Cardiol. 24 (1992) 1459-1470
25. Gwathmey J.K., Bentivegna L.A., Ransil B.J., Grossman W., and Morgan J.P. Relationship of abnormal intracellular calcium mobilization to myocyte hypertrophy in human ventricular myocardium. Cardiovascular Research 27 (1993) 199-203
26. 2+. Circulation 82 (1990) 1266-1278
27. Gwathmey J.K., Slawsky M.T., Hajjar R.J., Briggs G.M., and Morgan J.P. Role of intracellular calcium handling in force interval relationships of human ventricular myocardium. J. Clin. Invest. 85 (1990) 1599-1628
28. Gwathmey J.K., Copelas L., MacKinnon R., Schoen F.J., Feldman M.D., Grossman W., and Morgan J.P. Abnormal intracellular calcium handling in myocardium from patients with endstage heart failure. Circ. Res. 61 (1987) 70-76
29. Hajjar R.J., Liao R., Young J.B., Fuleihan F., Glass M.G., and Gwathmey J.K. Pathophysiological and biochemical characterization of an avian model of dilated cardiomyopathy: Comparison to findings in human dilated cardiomyopathy. Cardiovasc. Res. 27 (1993) 2212-2221
30. Hajjar R.J., and Gwathmey J.K. Cross-bridge dynamics in human ventricular myocardium. Regulation of contractility in the failing myocardium. Circulation 86 (1992) 1819-1826
31. 2+ in intact and skinned trabeculae from control and myopathic human hearts. J. Clin. Invest. 85 (1988) 1578-1584
32. Hasenfuss G., Mulieri L.A., Leavitt B.J., Allen P.D., Haeberle J.R., and Alpert N.R. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ. Res. 70 (1992) 1225-1232
33. 2+-ATPase in failing and nonfailing myocardium. Circ. Res. 75 (1994) 434-442
34. Holmberg S.R.M., and Williams A.G. Single-channel recordings from human cardiac sarcoplasmic reticulum. Circ. Res. 65 (1989) 1445-1449
35. Jeck C.D., Zimmermann R., Schaper J., and Schaper W. Decreased expression of calmodulin mRNA in human endstage heart failure. J. Mol. Cell. Cardiol. 26 (1994) 99-107
36. Kadambi V.J., Ponniah S., Harrer J.M., Hoit B.D., Dorn G.W., Walsh R.A., and Kranias E.G. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J. Clin. Invest. 97 (1996) 533-539
37. Katz A.M. Cell death in the failing heart: Role of an unnatural growth response to overload. Clin. Cardiol. 18 (1995) 36-44 Suppl.
38. Kitakaze M., Weisman H.F., and Marban E. Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts. Circulation 77 (1988) 685-695
39. Loewe O., Moscella M.C., Watras J., Handa K.K., Fyfe B.S., and Marks A.R. Differential regulation of two types of intracellular calcium release channels during endstage heart failure. J. Clin. Invest. 95 (1995) 888-894
40. Liao R., Nascimben L., Friedrich J., Gwathmey J.K., and Ingwall J.S. Decreased energy reserve in an animal model of dilated cardiomyopathy. Circ. Res. 78 (1996) 893-902
41. Luo W., Wolska B.M., Grupp I.I., Harrer J.M., Haghighi K., Ferguson D.G., Slack J.P., Grupp G., Doetschmann T., Solaro R.J., and Kranias E.G. Phospholamban gene dosage effects in the mammalian heart. Circ. Res. 78 (1996) 839-847
42. Margossian S.S., White H.D., Caulfield J.B., Norton P., Taylor S., and Slayter H.S. Light chain 2 profile and activity of human ventricular myosin during dilated cardiomyopathy: Identification of a causal agent for impaired myocardial function. Circulation 85 (1992) 1720-1733
43. 2+ -ATPase gene expression in the human ventricle during endstage heart failure. J. Clin. Invest. 85 (1990) 305-309
44. Mewes T., and Ravens U. L-type calcium channel currents of human myocytes from ventricle of nonfailing and failing hearts and atrium. J. Mol. Cell Cardiol. 26 (1990) 1307-1320
45. Meyer M., Schillinger W., Pieske B., Holubarsch C., Heilmann C., Posival H., Kuwajima G., Mikoshiba K., Just H., and Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92 (1995) 778-784
46. Movsessian M.A., Leveille C., Krall J., Colyer J., Wang J.H., and Campbell K.P. Identification and characterization of proteins in sarcoplasmic reticulum from normal and failing human left ventricles. J. Mol. Cell Cardiol. 22 (1990) 1477-1485
47. Narula, J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, G. W., and Khaw, B -A. 1996 Programmed cardiomyocyte death is present in endstage dilated cardiomyopathy. New Eng. J. Med. (in press).
48. 2+ accumulation in nonfailing and failing human myocardium. Circulation 92 (1995) 2504-2510
49. 2+ and ATP cycling imbalances in endstage idiopathic dilated and ischemic cardiomyopathies. Cardiovasc. Res. 30 (1995) 394-404
50. Orrenius S., and Nicotera P. The calcium ion and cell death. J. Neur. Trans. 43 (1994) 1-11 Suppl.
51. Pagani E.D., Alousi A.A., Grant A.M., Older T.M., Dziuban S.W., and Allen P.D. Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency. Circ. Res. 63 (1988) 380-385
52. Putney J.W., Takemura H., Hughes A.R., Horstmann D.A., and Tharsrurp O. How do inositol phosphates regulate calcium cycling. FASEB J. 3 (1989) 1899-1905
53. Rasmussen R.P., Minobe W., and Bristow M. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium. Biochem. Pharmacol. 39 (1988) 691-696
54. 2+ sparks and local control theories for cardiac excitation-contraction coupling. Circ. Res. 78 (1996) 166-171
55. 2+ channel in human myocardium. Anesthesiology 79 (1993) 332-339
56. Schmidt U., Hajjar R.J., Schwinger R.H.G., Bavendiek U., DiSalvo T.G., Semigram M.J., Dec W.G., and Gwathmey J.K. Differential effect of cAMP and Protein kinase A on sarcoplasmic reticulum Ca uptake in failing and nonfailing human myocardium. JACC 27 (1996) 114A suppl. (abstract
57. Schwinger R.H.G., Böhm M., and Erdmann E. Negative isotropic properties of isradipine, nifedipine diltiazem and verapamil in diseased human myocardial tissue. J. Cardiovasc. Pharmacol. 15 (1996) 892-899
58. 2+ ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92 (1995) 3220-3228
59. 2+ sparks). originate at transverse tubules in rat heart cells. J. Physiol. 487 (1995) 601-608
60. Siri F.M., Krueger J., Nordin C., Ming Z., and Aronson D.S. Depressed intracellular calcium transients and contraction in myocytes from hypertrophied and failing guinea pig hearts. Am. J. Physiol. 261 (1991) H514-H530
61. Solaro R.J., Powers F.M., Lizhu G., and Gwathmey J.K. Control of myofilament activation in heart failure. Circulation 87 (1993) 38-43 Suppl. VII
62. 2+ exchanger in endstage human heart failure. Circ. Res. 75 (1992) 443-453
63. 2+). channel and calsequestrin genesis the myocardium of patients with endstage heart failure. J. Clin. Inv. 90 (1992) 927-935
64. 2+ exchanger on cultured cardiac myocytes. Biochem. Biophys. Res. Comm. 212 (1995) 524-530
65. Trahir T., Yeoh T., and Cartmill T. Myosin light chain gene expression associated with disease states of the human heart. J. Moll. Cell Cardiol. 25 (1993) 577-585
66. Trautwein W., and Hescheler J. Regulation of cardiac L-type calcium current by phosphorylation and G-proteins. Ann. Rev. Physiol. 52 (1990) 257-274
67. Vahl C.E., Bonz A., Timek T., and Hagl S. Intracellular calcium transients of working human myocardium of seven patients transplanted for congestive heart failure. Circ. Res. 74 (1994) 952-958
68. Valente M., Calabrese F., Baliello E., Basso C., Angelini A., and Thiene G. Programmed myocardial cell death (apoptosis) in cardiomyopathies. J. Am. Coll. Cardiol. 27 (1996) 56 suppl. A). (abstract
69. Wankerl M., Bohm M., Morano I., Ruegg C., Eichhorn M., and Erdmann E. Calcium sensitivity and myosin light chain pattern of atria and ventricular skinned cardiac fibers from patients with various kinds of cardiac disease. J. Mol. Cell Cardiol. 22 (1990) 1425-1438
70. Wier W.G. Excitation-contraction coupling in mammalian ventricle. In: Gwathmey J.K., Briggs G.M., and Allen P.D. (Eds). Heart Failure Basic Science and Clinical Aspects (1993), Marcel Dekker. Inc, New York 11-38
71. Wier W.G., Egad T.M., Lopez-Lopez J.R., and Balke C.W. Local control of excitation-contraction coupling in rat heart cells. J. Physiol. 474 (1994) 463-471
72. 2+] transients in the cardiomyopathic hamster heart. Circ. Res. 68 (1991) 45-51